2022
DOI: 10.1007/s41649-022-00229-y
|View full text |Cite
|
Sign up to set email alerts
|

A Preliminary Study to Explore the Informed Consent Approach and the Ethical Challenges in the Malaysian Biobanking for Research

Abstract: Since 2005, Malaysia has established several biobanks to keep in line with the advancement of biomedical research and development of biobanks in other countries such as the UK and the USA. Despite the establishment of several biobanks in Malaysia, little is known about the informed consent approach in biobanking research and its ethical challenges. This study aims to identify the approach in obtaining informed consent in the Malaysian biobanking for research and explore its ethical challenges. Using non-probab… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 21 publications
(23 reference statements)
0
1
0
Order By: Relevance
“…Consequently, members of research ethics committees (RECs) face challenges when reviewing genomic research (Huanhuan et al, 2021). For instance, RECs in LMICs might lack the necessary expertise (Ochieng et al, 2020) and fail to realize the proper recognition of their exact roles and levels of oversight when reviewing genomic research (Azahar et al, 2023). Finally, the lack of national regulatory frameworks governing biobank research in LMICs might lead to inconsistency among RECs in reviewing such research (Vodosin et al, 2021).…”
Section: Introductionmentioning
confidence: 99%
“…Consequently, members of research ethics committees (RECs) face challenges when reviewing genomic research (Huanhuan et al, 2021). For instance, RECs in LMICs might lack the necessary expertise (Ochieng et al, 2020) and fail to realize the proper recognition of their exact roles and levels of oversight when reviewing genomic research (Azahar et al, 2023). Finally, the lack of national regulatory frameworks governing biobank research in LMICs might lead to inconsistency among RECs in reviewing such research (Vodosin et al, 2021).…”
Section: Introductionmentioning
confidence: 99%